Marqibo contains the same active ingredient as Oncovin from Eli Lilly, encapsulated in a new technology that could make it target tumors better.    From Wordnik.com.  [Hana Biosciences To Pay Up to $42 Million For Drugs] Reference

Marking the launch of its new initiative to accelerate the development of blood cancer therapies, The Leukemia & Lymphoma Society today announced a collaboration with Ensemble Discovery Corp. of Cambridge, MA. Doxil, Oncovin, Revlimid and Dexamethasone Effective in Recurrent Multiple Myeloma.    From Wordnik.com.  [xml's Blinklist.com] Reference

According to an article recently published in the Annals of Oncology, a treatment combination of Revlimid® (lenalidomide), Oncovin® (vincristine), Doxil® (pegylated doxorubicin) and dexamethasone appears highly effective in multiple myeloma that has recurred or progressed following prior therapies.    From Wordnik.com.  [xml's Blinklist.com] Reference

Compared with CHOP -- cyclophosphamide, hydroxydaunorubicin, vincristine (Oncovin), and prednisone -- plus rituximab, the combination of bendamustine and rituximab showed substantially lower toxicity and better complete response rates in a randomized Phase III trial, reported Mathias Rummel, MD, PhD, of University Hospital in Giessen, Germany.    From Wordnik.com.  [MedPageToday.com - medical news plus CME for physicians] Reference

Oncovin.    From Wordnik.com.  [Blood Test]